Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. (SHE:301234)

SHE:301234 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Revenue Revenue Growth	444.41	458.28	477.43	533.68	547.11	512.96
Revenue Growth	-7.84%	-4.01%	-10.54%	-2.46%	6.66%	8.85%
Gross Profit Gross Profit Growth	70.36	65.3	81.9	111	118.38	113.26
Operating Income Operating Income Growth	23.88	17.21	32.55	57.56	55.25	78.19
Net Income Net Income Growth	23.74	18.89	39.97	60.27	70.93	68.39
Earnings Per Share EPS Growth	0.35	0.28	0.59	0.89	1.19	1.34
EPS Growth	-17.33%	-52.74%	-33.68%	-25.65%	-11.10%	20.81%

Revenue by Geography

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Overseas Overseas Growth	441.69	462.53	519.93	531.04	493.32
China China Growth	16.59	14.9	13.75	16.07	19.64
Total Total Growth	458.28	477.43	533.68	547.11	512.96

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Investments Cash & Investments Growth	412.95	418.88	376.82	346.56	364.82	43.33
Total Debt Total Debt Growth	0.49	0.25	0.82	0.25	0.61	12.83
Net Cash (Debt) Net Cash Growth	412.46	418.63	376	346.31	364.21	30.5
Net Cash Growth	3.64%	11.34%	8.57%	-4.92%	1094.16%	33.45%
Net Cash Per Share Net Cash Per Share Growth	6.06	6.16	5.53	5.09	6.12	0.60

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Operating Cash Flow Operating Cash Flow Growth	51.85	73.38	88.9	81.79	111.45	62.58
Capital Expenditures CapEx Growth	-29.37	-19.78	-37	-70.87	-163.96	-56.51
Free Cash Flow Free Cash Flow Growth	22.48	53.61	51.9	10.92	-52.51	6.07
Free Cash Flow Growth	-61.97%	3.29%	375.48%	-	-	-71.51%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Gross Margin	15.83%	14.25%	17.16%	20.80%	21.64%	22.08%
Operating Margin	5.37%	3.75%	6.82%	10.79%	10.10%	15.24%
Pretax Margin	6.07%	5.00%	9.73%	13.29%	13.42%	15.56%
Profit Margin	5.34%	4.12%	8.37%	11.29%	12.96%	13.33%
FCF Margin	5.06%	11.70%	10.87%	2.04%	-9.60%	1.18%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023
Dividend Per Share Dividend Per Share Growth	0.200	0.200	0.300	0.400	0.500
Dividend Per Share Growth	-33.33%	-33.33%	-25.00%	-20.00%	-
Dividend Yield	0.19%	0.47%	1.21%	1.22%	1.80%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
PE Ratio	285.30	152.97	42.79	38.23	28.08	-
P/FCF Ratio	301.24	53.91	32.95	211.06	-	-
PS Ratio	15.24	6.31	3.58	4.32	3.64	-

Data Source: S&P Global Market Intelligence Last updated: Aug 23, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 13, 2026

Data Sources Report a data error